s6y

Astria Therapeutics, Inc.

CIK
1454789
Industry
Pharmaceutical Preparations
Formerly
CATABASIS PHARMACEUTICALS INC

Financials 43

  1. 10-Q Quarterly Report for period ending Sep 30, 2025
  2. 10-Q Quarterly Report for period ending Jun 30, 2025
  3. 10-Q Quarterly Report for period ending Mar 31, 2025
  4. 10-K Annual Report for period ending Dec 31, 2024
  5. 10-Q Quarterly Report for period ending Sep 30, 2024
  6. 10-Q Quarterly Report for period ending Jun 30, 2024
  7. 10-Q Quarterly Report for period ending Mar 31, 2024
  8. 10-K Annual Report for period ending Dec 31, 2023
  9. 10-Q Quarterly Report for period ending Sep 30, 2023
  10. 10-Q Quarterly Report for period ending Jun 30, 2023

All 43 financials filings

News 84

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 84 news filings

Ownership 305

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 305 ownership filings

Prospectus 83

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 POS Post-effective amendment to a S-8 registration statement
  7. S-8 POS Post-effective amendment to a S-8 registration statement
  8. S-8 POS Post-effective amendment to a S-8 registration statement
  9. S-8 POS Post-effective amendment to a S-8 registration statement
  10. S-8 POS Post-effective amendment to a S-8 registration statement

All 83 prospectus filings

Proxies 28

  1. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEF 14A Definitive proxy statements
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEF 14A Definitive proxy statements

All 28 proxies filings

Other 85

  1. SCHEDULE 13G/A
  2. SCHEDULE 13G/A
  3. SCHEDULE 13D/A
  4. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  5. SCHEDULE 13D/A
  6. EFFECT Notice of Effectiveness
  7. EFFECT Notice of Effectiveness
  8. EFFECT Notice of Effectiveness
  9. EFFECT Notice of Effectiveness
  10. EFFECT Notice of Effectiveness

All 85 other filings